Paclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial.

Seminars in oncology

Volumn 24, Issue 1 Suppl 3, 1997, Pages

  Johnson, D H ^a   Paul, D ^a   Hande, K R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; PACLITAXEL;

ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG EFFECT; FATIGUE; FEMALE; HUMAN; METASTASIS; MIDDLE AGED; MUCOSA; NEUROLOGIC DISEASE; PHASE 2 CLINICAL TRIAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FATIGUE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM METASTASIS; NERVOUS SYSTEM DISEASES; PACLITAXEL;

EID: 0031067854     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)